Consolidated Statement Of Cash Flows
Japan Animal Referral Medical Center Co.,Ltd. - Filing #7298565
Concept |
As at 2024-09-30 |
2024-04-01 to 2024-09-30 |
As at 2024-03-31 |
As at 2023-09-30 |
2023-04-01 to 2023-09-30 |
As at 2023-03-31 |
---|---|---|---|---|---|---|
Consolidated statement of cash flows | ||||||
Statement of cash flows | ||||||
Cash flows from operating activities | ||||||
Profit (loss) before income taxes | — |
351,992,000
JPY
|
— | — |
153,548,000
JPY
|
— |
Depreciation | — |
264,997,000
JPY
|
— | — |
204,135,000
JPY
|
— |
Amortization of goodwill | — |
10,184,000
JPY
|
— | — |
10,184,000
JPY
|
— |
Increase (decrease) in allowance for doubtful accounts | — |
1,629,000
JPY
|
— | — |
406,000
JPY
|
— |
Interest expenses | — |
11,884,000
JPY
|
— | — |
9,320,000
JPY
|
— |
Increase (decrease) in provision for bonuses | — |
15,144,000
JPY
|
— | — |
17,354,000
JPY
|
— |
Increase (decrease) in retirement benefit liability | — |
4,150,000
JPY
|
— | — |
450,000
JPY
|
— |
Decrease (increase) in trade receivables | — |
-10,194,000
JPY
|
— | — |
3,645,000
JPY
|
— |
Subtotal | — |
645,257,000
JPY
|
— | — |
507,715,000
JPY
|
— |
Income taxes paid | — |
-68,536,000
JPY
|
— | — |
-133,623,000
JPY
|
— |
Decrease (increase) in inventories | — |
-20,235,000
JPY
|
— | — |
16,136,000
JPY
|
— |
Net cash provided by (used in) operating activities | — |
565,255,000
JPY
|
— | — |
364,622,000
JPY
|
— |
Increase (decrease) in trade payables | — |
2,644,000
JPY
|
— | — |
-12,648,000
JPY
|
— |
Other, net | — |
-3,693,000
JPY
|
— | — |
28,734,000
JPY
|
— |
Interest and dividends received | — |
125,000
JPY
|
— | — |
19,000
JPY
|
— |
Interest paid | — |
-12,131,000
JPY
|
— | — |
-9,489,000
JPY
|
— |
Cash flows from investing activities | ||||||
Purchase of property, plant and equipment | — |
-688,691,000
JPY
|
— | — |
-774,488,000
JPY
|
— |
Proceeds from sale of property, plant and equipment | — |
JPY
|
— | — |
1,449,000
JPY
|
— |
Net cash provided by (used in) investing activities | — |
-711,840,000
JPY
|
— | — |
-789,167,000
JPY
|
— |
Other, net | — |
643,000
JPY
|
— | — |
6,414,000
JPY
|
— |
Cash flows from financing activities | ||||||
Proceeds from issuance of shares | — |
8,750,000
JPY
|
— | — |
JPY
|
— |
Purchase of treasury shares | — |
-172,391,000
JPY
|
— | — |
JPY
|
— |
Dividends paid | — |
-52,523,000
JPY
|
— | — |
JPY
|
— |
Proceeds from long-term borrowings | — |
300,000,000
JPY
|
— | — |
489,900,000
JPY
|
— |
Repayments of long-term borrowings | — |
-340,851,000
JPY
|
— | — |
-290,045,000
JPY
|
— |
Net cash provided by (used in) financing activities | — |
-262,594,000
JPY
|
— | — |
198,468,000
JPY
|
— |
Repayments of lease liabilities | — |
-3,647,000
JPY
|
— | — |
-2,676,000
JPY
|
— |
Other, net | — |
-1,930,000
JPY
|
— | — |
-1,709,000
JPY
|
— |
Effect of exchange rate change on cash and cash equivalents | — |
JPY
|
— | — |
JPY
|
— |
Net increase (decrease) in cash and cash equivalents | — |
-409,179,000
JPY
|
— | — |
-226,076,000
JPY
|
— |
Cash and cash equivalents |
928,460,000
JPY
|
— |
1,337,639,000
JPY
|
1,589,963,000
JPY
|
— |
1,816,039,000
JPY
|